2011 annual financial data
Anika Therapeutics 2011 Operating margin
Anika Therapeutics 2011 operating margin with verified reported values.
Direct answer
Operating margin was 21.56%.
Operating income was 13,967,402 USD and net income was 8,466,680 USD.
Operating cash flow was 10,173,134 USD.
Get free Anika Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 64,778,635 USD
- Operating income
- 13,967,402 USD
- Net income
- 8,466,680 USD
- Operating cash flow
- 10,173,134 USD